Abstract:Background Skin fibrosis is the typical pathological manifestation of systemic sclerosis (SSc) and localized scleroderma (LS); it has an unclear aetiology and few effective treatments. Although excessive collagen secretion by fibroblasts is the primary cause of skin fibrosis, evidence has suggested that vascular damage is the initiating event and that various cell types, including fibroblasts, work together to contribute to the pathogenesis of skin fibrosis.Objectives To explore the relationship between vascular endothelial cell lesions and immune cell infiltration, along with the interactions between various cell types within the fibrotic skin ecosystem.Methods Single-cell RNA sequencing was performed on skin biopsies from three healthy donors and seven patients with SSc. Additional data from three patients with localized scleroderma available in the Gene Expression Omnibus (GSE160536) were integrated by Harmony. CellChat (version 1.5.0) was used to analyse the cell communication network. A Transwell (R) assay and a bleomycin (BLM) mouse model were used to explore the role of atypical chemokine receptor 1 (ACKR1; 'Duffy antigen') in immune cell infiltration. Milo single-cell Western blot was used to show fibroblast subcluster activation.Results A total of 62 295 cells were obtained and subpopulations of stromal and immune cells identified. Interaction network analysis found that multiple chemokines secreted by macrophages, pericytes and proinflammatory fibroblasts could bind with ACKR1, which was highly expressed by endothelial cells in lesional skin. The Transwell (R) assay revealed that overexpression of ACKR1 in human umbilical vein endothelial cells facilitated leucocyte infiltration following treatment with interleukin-8. BLM mice showed enhanced ACKR1 expression, massive immune cell infiltration and skin fibrosis that was attenuated by ACKR1 inhibition. Furthermore, infiltrated macrophages expressing high levels of transforming growth factor (TGF)-beta 1 or platelet-derived growth factor B (PDGFB) could activate secreted frizzled-related protein 2 (SFRP2)/asporin (ASPN)+ fibroblasts to contribute to the excessive accumulation of extracellular matrix. It was also found that the SOX4-ASPN axis plays an important role in the TGF-beta signalling cascade and the aetiology of skin fibrosis.Conclusions Our results reveal that high expression of ACKR1 by endothelial cells in fibrotic skin tissue promotes immune cell infiltration and that SFRP2/ASPN+ fibroblasts synergize to exacerbate skin fibrosis. Graphical Abstract We performed a systemic characterization of the interactions between various cell types in fibrotic skin tissues, providing novel insights into the mechanism of skin fibrosis. We identified a cluster of atypical chemokine receptor 1 (ACKR1)+ endothelial cells that are highly expressed in fibrotic skin tissue, and found that ACKR1+ endothelial cells could promote immune cell infiltration and mediate the development of skin fibrosis, providing a theoretical basis for potential anti-ACKR1 treatment in skin fibrosis. Infiltrating macrophages activated SFRP2/ASPN+ fibroblasts by secreting TGF-beta 1 and PDGFB, suggesting a role of macrophage-fibroblast interactions in skin fibrosis. The SOX4-ASPN axis plays an important role in the TGF-beta signalling cascade and aetiology of skin fibrosis. Skin fibrosis is characterized by thickening or hardening of the skin. It occurs in a number of skin diseases. It has been suggested that different cell types work together to contribute to the processes involved in skin fibrosis.In this study, we looked at interactions between different cell types involved in two different fibrotic skin diseases called 'systemic sclerosis' and 'localized scleroderma'. We found that many signalling proteins produced by certain cell types interacted strongly with a protein called 'ACKR1'. Other investigations showed that high levels of ACKR1 aggravated skin fibrosis. Finally, 'macrophages' (a type of white blood cell) that produced high levels of two different proteins caused skin fibrosis to worsen.Overall, our study findings provide a deeper insight into cellular interactions that might cause skin fibrosis to develop. This may lead to new treatments for these two diseases.

Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis

Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase–like 4: New Evidence from Three‐Dimensional Skin‐like Tissues

TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis

Mutual amplification of GLI2/Hedgehog and cJUN/AP1 signaling in fibroblasts in Systemic Sclerosis (SSc) – potential implications for combined therapies

[Transforming Growth Factor-Beta and Its Receptors in Scleroderma].

Role of endothelin-1 in the skin fibrosis of systemic sclerosis

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

Therapeutic Targeting of Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis

PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1

Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis

Atypical Chemokine Receptor 1-Positive Endothelial Cells Mediate Leucocyte Infiltration and Synergize with Secreted Frizzled-Related Protein 2/Asporin-Positive Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis.

Transforming Growth Factor-β Receptor Type I-dependent Fibrogenic Gene Program is Mediated Via Activation of Smad1 and ERK1/2 Pathways

ACKR1+ Endothelial Cells Mediate Leukocyte Infiltration and Synergize with SFRP2/ASPN+ Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis

CXCL4 drives fibrosis by promoting several key cellular and molecular processes

Isoform-selective TGF-β3 inhibition for systemic sclerosis

Critical role for the TGF-β1/mTORC1 signalling axis in defining the transcriptional identity of CTHRC1+ pathologic fibroblasts

The role and mechanism of CRISPLD2 in skin fibrosis of systemic sclerosis

A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling

Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin

Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation

Enhancement of Zyxin Promotes Skin Fibrosis by Regulating FAK/PI3K/AKT and TGF-13 Signaling Pathways via Integrins